AD patients have abnormal levels of ribosomal RNAs (rRNA18S, rRNA28S), ribosomal proteins (rpS5, rpS6, rpS10, rpS13), initiation factors (eIF3eta), and elongation factors (eEF1A, eEF2), suggesting aberrant protein synthesis. Here, RPS5 is linked to Alzheimer disease.